Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Bioengineered ; 13(5): 12738-12748, 2022 05.
Article in English | MEDLINE | ID: mdl-35609322

ABSTRACT

Phosphatidylinositol Transfer Protein, Membrane-Associated 3 (PITPNM3) often bind with chemokine (C-C motif) ligand 18 (CCL18) to promote tumor progression. However, the role of PITPNM3 in intrahepatic cholangiocarcinoma (ICC) is unclear. We first searched GEPIA database and detected the PITPNM3 expression using immunohistochemistry and real-time quantitative PCR. The results showed that PITPNM3 is high expression in ICC tissues and cells. Then we investigated the cell function of CLL18 and PITPNM3 through cell clone formation assay and transwell assay. The results indicated that CCL18 treatment promoted the proliferation, migration, and invasion of ICC cells. Silence of PITPNM3 reversed the effect of CCL18 on cell function. Simultaneously, we detected key protein expression of forkhead box O1 (FOXO1) and nuclear factor kappa B (NF-KB) through western blotting and found that CCL18 activated NF-KB pathway while inhibited FOXO1 pathway, the effect of which were attenuated by silence of PITPNM3. Finally, we confirmed which pathway affected the cell function using inhibitor of FOXO1 (AS1842856) and activator of NF-KB (Asatone). The results showed that AS1842856, not Asatone, relieved the inhibitory effect of si-PITPNM3 on the cell function of CCL18. In short, CCL18 treatment activated PITPNM3 to promote the proliferation, migration, and invasion of ICC via FOXO1 signaling pathway. These results provided a new insight for the diagnosis and therapy of ICC.


Subject(s)
Bile Duct Neoplasms , Cholangiocarcinoma , Bile Duct Neoplasms/genetics , Bile Ducts, Intrahepatic/metabolism , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation/genetics , Cholangiocarcinoma/genetics , Humans , Ligands , NF-kappa B/metabolism
2.
Phys Chem Chem Phys ; 20(35): 22997-23006, 2018 Sep 12.
Article in English | MEDLINE | ID: mdl-30156234

ABSTRACT

Singlet fission (SF) is a spin-allowed process, which is expected to be a feasible strategy to realize photon downward conversion. To achieve a significant increase in the photoelectric conversion efficiency of solar cells, SF molecules should have not only a high SF efficiency, but also suitable energies of the first singlet excited state [E(S1)] and the first triplet excited state [E(T1)] to act as SF sensitizers in solar cells. Aryl-substituted diketopyrrolopyrrole (DPP) is one of the few organic molecules, which can undergo SF efficiently after photoexcitation. In order to find suitable DPP-based SF sensitizers for solar cells, we designed a series of DPP derivatives by varying aromatic substituents, including changing the conjugation and constitution of aromatic substituents, as well as introducing side-substituents on the aromatic substituents. Detailed analysis focused on the molecular structures, the frontier molecular orbitals, multiple diradical characters, and SF relevant excited-state energy levels. The results indicate that introduction of no more than two aromatic rings and modification of the aromatic rings with side-substituents are both practical ways to get suitable SF sensitizers for solar cells. This work would give a deep understanding of DPP-based SF molecules, and pave the way towards the development of new DPP-based SF sensitizers for solar cells.

3.
Phys Chem Chem Phys ; 20(9): 6330-6336, 2018 Feb 28.
Article in English | MEDLINE | ID: mdl-29435544

ABSTRACT

A covalently linked tetracene trimer with a "face-to-face" stacked structure was prepared and its molecular structure is characterized by 1H NMR, MALDI-TOF mass spectroscopy, and elemental analysis. The minimized molecular structure reveals that three tetracene subunits within this trimer adopt a partially "face-to-face" stacked configuration. Its absorption spectrum differs significantly from that of the monomeric and dimeric counterparts in solution due to the strong ground state interactions between the neighboring tetracene subunits. Its fluorescence is almost quenched completely. An ultrafast fluorescence decay component is observed in its fluorescence dynamics, indicating the presence of an ultrafast nonradiative decay channel in the trimer. The nonradiative channel is proved to be intramolecular singlet fission (iSF) by femto-second transient absorption studies. Different from the strongly coupled triplet state observed in the corresponding dimer, weakly coupled triplet states can be formed in this trimer. The triplet quantum yield of trimer 4 can reach up to 126% in solution.

4.
Dalton Trans ; 45(48): 19329-19340, 2016 Dec 06.
Article in English | MEDLINE | ID: mdl-27872925

ABSTRACT

A series of mononuclear ruthenium arene complexes with thiosemicarbazone (TSC) ligands (A-type, 1-8) and their corresponding di-nuclear analogues (B-type, 9-16) were synthesized and characterized by NMR, elemental analysis and HR-ESI-mass spectrometry. The molecular structures of 1, 2, 6, 9-11 and 13-16 were determined using single-crystal X-ray diffraction analysis. The Gibbs free energy of the two examples of the two types of complexes (1 and 9) and the bonding order in their single-crystals were studied using density functional theory (DFT) calculations. The compounds were further evaluated for their in vitro antiproliferative activities against CNE-2 human nasopharyngeal carcinoma, KB human oral epithelial carcinoma, SGC-7901 human gastric carcinoma, HepG2 human liver carcinoma, HeLa human cervical carcinoma and HEK-293T noncancerous cell lines. Furthermore, the interactions between the compounds and DNA were studied by electrophoretic mobility spectrometry studies.


Subject(s)
Coordination Complexes/chemistry , Hydrocarbons/chemistry , Ruthenium Compounds/chemistry , Thiosemicarbazones/chemistry , Cell Line, Tumor , Coordination Complexes/pharmacology , Crystallography, X-Ray , Drug Screening Assays, Antitumor , Humans , Ligands , Molecular Structure
5.
Mini Rev Med Chem ; 16(10): 787-95, 2016.
Article in English | MEDLINE | ID: mdl-27161008

ABSTRACT

The organometallic arene ruthenium complexes are rapidly advancing. In particular, the organoruthenium complexes of the type [(η6-arene)Ru(X)(Y)(Z)] have attracted increasing attention for their special structures and properties. This review is focused on the recent developments of [(η6- arene)Ru(X)(Y)(Z)]-typed complexes incorporating various biologically active ligands, which are important in the exploration of novel multi-targeted organometallic anticancer drugs.


Subject(s)
Antineoplastic Agents/chemistry , Coordination Complexes/chemistry , Drug Discovery , Hydrocarbons, Aromatic/chemistry , Neoplasms/drug therapy , Ruthenium/chemistry , Animals , Antineoplastic Agents/pharmacology , Coordination Complexes/pharmacology , Drug Discovery/methods , Humans , Hydrocarbons, Aromatic/pharmacology , Ruthenium/pharmacology
6.
Nan Fang Yi Ke Da Xue Xue Bao ; 36(5): 665-70, 2016 May.
Article in Chinese | MEDLINE | ID: mdl-27222182

ABSTRACT

OBJECTIVE: To investigate the effect of solanine on the growth of human prostate cancer cell xenograft in nude mice. METHODS: Human prostate cancer Du145 cells were injected into the subcutaneous layers on the back of nude mice. After a week, the mice bearing subcutaneous tumor graft were randomly divided into solanine treatment group and saline control group for treatment for 3 weeks. The tumor grafts were then harvested to evaluate the inhibition rate. The mRNA and protein expressions of cell cycle-related genes in the tumors were detected by qRT-PCR and Western blotting, respectively, and tumor cell apoptosis was detected using TUNEL method. RESULTS: The tumor growth rate in solanine-treated group was significantly slower than that in the control group (P<0.01). The mRNA and protein expressions of C-myc, cyclin D1, cyclin E1, CDK2, CDK4 and CDK6 were significantly inhibited by solanine. Solanine significantly up-regulated p21 mRNA and protein expression in the tumors and induced a higher apoptosis rate of the tumor cells than saline (P<0.01). CONCLUSION: The tumor-inhibition effect of solanine is probably mediated by regulating the expressions of genes related with G1/S cell cycle arrest and cell apoptosis.


Subject(s)
G1 Phase Cell Cycle Checkpoints , Neoplasm Transplantation/pathology , Prostatic Neoplasms/pathology , Solanine/pharmacology , Animals , Apoptosis , Cyclin-Dependent Kinases/metabolism , Cyclins/metabolism , Humans , Male , Mice , Mice, Nude , Prostatic Neoplasms/drug therapy , S Phase
7.
Int J Clin Exp Med ; 8(8): 12593-600, 2015.
Article in English | MEDLINE | ID: mdl-26550170

ABSTRACT

To evaluate the effects of alginate scaffold-bone marrow stromal cell (BMSC) in the treatment of acute liver failure in rats and provide a basis for in vivo application of artificial liver tissue. CM-DiI-labeled BMSCs were planted and grown on alginate scaffolds to form alginate scaffold-BMSC complex. Alginate scaffold-BMSC complex (the experimental group) or alginate scaffolds (the control group) were placed onto the surface of liver wound of rats after 70% of hepatectomy. The scaffold-BMSC complex and alginate scaffolds were removed after 4 weeks and fluorescence microscopy was used to track the growth and distribution of CM-DiI-labeled BMSCs. The liver tissues were stained for albumin and glycogen to investigate the differentiation of BMSCs on alginate scaffolds. The survival rate and liver function were also compared between the two groups of rats. BMSCs on alginate scaffolds and liver tissues were clearly demonstrated by CM-DiI labeling. BMSCs on alginate scaffolds secreted albumin and produced glycogen. The survival rate and liver function of the rats of the experimental group were significantly higher than that the control group rats. Alginate scaffold-BMSC complex promotes the regeneration of liver tissues in rats of acute liver failure.

8.
Cytotherapy ; 15(10): 1266-74, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23993301

ABSTRACT

BACKGROUND AIMS: Assessing mesenchymal stromal cells (MSCs) after grafting is essential for understanding their migration and differentiation processes. The present study sought to evaluate via cellular magnetic resonance imaging (MRI) if transplantation route may have an effect on MSCs engrafting to fibrotic liver of rats. METHODS: Rat MSCs were prepared, labeled with superparamagnetic iron oxide and scanned with MRI. Labeled MSCs were transplanted via the portal vein or vena caudalis to rats with hepatic fibrosis. MRI was performed in vitro before and after transplantation. Histologic examination was performed. MRI scan and imaging parameter optimization in vitro and migration under in vivo conditions were demonstrated. RESULTS: Strong MRI susceptibility effects could be found on gradient echo-weighted, or T2∗-weighted, imaging sequences from 24 h after labeling to passage 4 of labeled MSCs in vitro. In vivo, MRI findings of the portal vein group indicated lower signal in liver on single shot fast spin echo-weighted, or T2-weighted, imaging and T2∗-weighted imaging sequences. The low liver MRI signal increased gradually from 0-3 h and decreased gradually from 3 h to 14 days post-transplantation. The distribution pattern of labeled MSCs in liver histologic sections was identical to that of MRI signal. It was difficult to find MSCs in tissues near the portal area on day 14 after transplantation; labeled MSCs appeared in fibrous tuberculum at the edge of the liver. No MRI signal change and a positive histologic examination were observed in the vena caudalis group. CONCLUSIONS: The portal vein route seemed to be more beneficial than the vena caudalis on MSC migration to fibrotic liver of rats via MRI.


Subject(s)
Fibrosis/diagnosis , Liver/diagnostic imaging , Magnetic Resonance Imaging/methods , Mesenchymal Stem Cell Transplantation , Stem Cells/metabolism , Animals , Carbon Tetrachloride/administration & dosage , Cell Differentiation , Cell Movement , Cells, Cultured , Ferric Compounds/metabolism , Fibrosis/chemically induced , Fibrosis/therapy , Liver/pathology , Male , Portal Vein/diagnostic imaging , Portal Vein/metabolism , Radionuclide Imaging , Rats , Rats, Wistar , Stem Cells/diagnostic imaging , Stem Cells/pathology
9.
Rev Sci Instrum ; 81(7): 074301, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20687743

ABSTRACT

The most difficult, time-consuming, and complication-prone step in pancreaticoduodenectomy is the pancreaticojejunostomy step. The largest disadvantage of this kind of anastomosis is the high incidence of postoperative anastomotic leakage. Once pancreatic leakage occurs, the patient death rate can be very high. The aim of this study was to design a pancreaticojejunostomy procedure using anastomotic chains, which results in the cut end of the jejunum being attached to the pancreatic stump without suturing, and to evaluate the safety and efficacy of this procedure in domestic pigs. The pancreaticojejunal anastomotic chains had the following structures: the chains consisted of two braceletlike chains made of titanium, named chain A and chain B. The function of chain A was to attach the free jejunal end onto the pancreatic stump, whereas the function of chain B was to tighten the contact between the jejunal wall and the surface of the pancreatic stump to eliminate gaps between the two structures and ensure tightness that is sufficient to guarantee that there is no leakage of jejunal fluid or pancreatic juice. The following procedure was used to assess the safety and efficacy of the procedure: pancreaticojejunostomies were performed on ten domestic pigs using anastomotic chains. The time required to complete the pancreaticojejunal anastomoses, the pressure tolerance of the pancreaticojejunal anastomoses, the pig death rate, and the histopathological examinations of the pancreaticojejunostomy tissues were recorded. The average time required to complete the pancreaticojejunal anastomosis procedure was 13+/-2 min. The observed tolerance pressure of the pancreaticojejunal anastomoses was more than 90 mm H(2)O. All ten domestic pigs that underwent operations were still alive four weeks after the operations. Pathological examinations showed that the anastomotic surfaces were completely healed, and the pancreatic cutting surfaces were primarily epithelialized. In conclusion, the use of anastomotic chains in pancreaticojejunostomy procedures results in a decrease in or elimination of pancreatic leakage. In addition, the procedure is simple to perform, is not time-intensive, and appears to be safe in a pig model.


Subject(s)
Pancreaticojejunostomy/methods , Animals , Jejunum/surgery , Pancreas/surgery , Pancreaticojejunostomy/instrumentation , Swine
10.
Dig Dis Sci ; 55(9): 2664-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-19949862

ABSTRACT

BACKGROUND: Curative percutaneous microwave coagulation therapy is difficult or contraindicated in patients with tumors adjacent to the gallbladder because of the associated risk of injury. To date, no clinical data have been published regarding the effects and safety of percutaneous microwave coagulation therapy on tumors that are adjacent to the gallbladder. AIMS: We investigated the efficacy and safety of a combined treatment involving laparoscopic cholecystectomy and subsequent percutaneous microwave coagulation therapy in patients with hepatocellular carcinoma adjacent to the gallbladder. METHODS: Twenty-three patients with hepatocellular carcinoma nodules (of less than 5 cm diameter) and adjacent to the gallbladder were treated by percutaneous microwave coagulation therapy with a "cooled-tip needle" after laparoscopic cholecystectomy. The therapeutic efficacy was evaluated with enhanced helical computed tomography and sonography, and the rates of complete necrosis as well as postoperative complications were also analyzed. RESULTS: All of the patients exhibited complete necrosis of their tumor lesions after treatment with percutaneous microwave coagulation therapy. During the follow-up period (which lasted more than 21 months), 22 of 23 patients were alive. Recurrent nodules appeared in other subsegments, but not at the original site treated with percutaneous microwave coagulation therapy. Of note, no fatal complications were observed in any of the patients treated with percutaneous microwave coagulation therapy. CONCLUSION: Our results suggest that combined treatment comprising both laparoscopic cholecystectomy and subsequent percutaneous microwave coagulation therapy is an effective and safe approach for patients with small (<5 cm) hepatocellular carcinomas that are adjacent to the gallbladder.


Subject(s)
Carcinoma, Hepatocellular/surgery , Catheter Ablation/methods , Cholecystectomy, Laparoscopic , Gallbladder/surgery , Liver Neoplasms/surgery , Microwaves/therapeutic use , Ultrasonography, Interventional , Adult , Aged , Carcinoma, Hepatocellular/diagnostic imaging , Catheter Ablation/adverse effects , Catheter Ablation/instrumentation , Equipment Design , Female , Gallbladder/diagnostic imaging , Humans , Liver Neoplasms/diagnostic imaging , Male , Microwaves/adverse effects , Middle Aged , Needles , Time Factors , Tomography, Spiral Computed , Treatment Outcome
11.
Dig Dis Sci ; 55(2): 438-45, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19242797

ABSTRACT

In this study, we determined whether the proliferation of bone marrow-derived mesenchymal stem cells (MSCs) is impaired in patients with chronic hepatitis B viral infection and cirrhosis of the liver. MSCs from 15 patients with chronic hepatitis B and cirrhosis of the liver (CIR-MSCs) and 11 normal donors (ND-MSCs) were collected and characterized in vitro. CIR-MSCs displayed an intact immunophenotype. The percentage of S-phase nuclei in CIR-MSCs (4.34%), however, was significantly lower than that in ND-MSCs (P < 0.001), indicating impaired proliferation of CIR-MSCs. Growth factor receptor expression (e.g., IGF1, PDGFalpha, and PDGFbeta) on the surface of CIR-MSCs decreased compared to that on ND-MSCs (P < 0.03). We found no evidence that CIR-MSCs were infected with the hepatitis B virus (HBV). Deficient proliferation of CIR-MSCs may result from the decreased expression of growth factor receptors and unbalanced production of cytokines in patients with HBV infection. Our results indicate that autologous MSCs of patients with chronic hepatitis B and cirrhosis of the liver may not be suitable for therapeutic purposes.


Subject(s)
Hepatitis B, Chronic/pathology , Liver Cirrhosis/pathology , Mesenchymal Stem Cells/pathology , Adult , Cell Proliferation , Cells, Cultured , Disease Progression , Female , Humans , Male , Mesenchymal Stem Cells/metabolism , Middle Aged , Receptors, Growth Factor/metabolism , Severity of Illness Index
12.
Life Sci ; 85(7-8): 291-5, 2009 Aug 12.
Article in English | MEDLINE | ID: mdl-19559033

ABSTRACT

AIMS: Multipotent mesenchymal stromal cells (MSC) have been reported to prevent the development of liver fibrosis and have emerged as a promising strategy for cell-based therapy. However, the underlying therapeutic mechanism remains unclear. Hepatic stellate cells (SC) activation is a pivotal event in the development of liver fibrosis. MAIN METHODS: We hypothesized that MSC play an important role in regulating SC proliferation and apoptosis through paracrine mechanisms. To investigate the paracrine interactions between MSC and SC, a co-culture experimental model was developed using human MSC (hMSC) and human SC (hSC). KEY FINDINGS: We demonstrate that hMSC and hSC both express nerve growth factor (NGF) receptor p75. Results acquired from transwell co-culture experiments using hSC and hMSC showed that hMSC secrete NGF, which enhances hSC apoptosis. Transcription factor nuclear factor kappa B (NF-KappaB) and B cell leukemia-xl (Bcl-xl) take part in the process. SIGNIFICANCE: These findings demonstrated that hMSC indirectly modulate activated hSC in vitro via NGF-mediated signaling cascades and provide a potential mechanism of how transplanted MSC are effective in treating liver fibrosis.


Subject(s)
Hepatic Stellate Cells/cytology , Mesenchymal Stem Cells/cytology , Multipotent Stem Cells/cytology , Nerve Growth Factor/physiology , Paracrine Communication/physiology , Apoptosis/physiology , Cell Proliferation/drug effects , Cells, Cultured , Coculture Techniques , Culture Media , Genetic Vectors , Hepatic Stellate Cells/drug effects , Hepatic Stellate Cells/metabolism , Humans , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/metabolism , Multipotent Stem Cells/drug effects , Multipotent Stem Cells/metabolism , Nerve Growth Factor/biosynthesis , Nerve Growth Factor/metabolism , Nerve Growth Factor/pharmacology , Paracrine Communication/drug effects , Receptor, Nerve Growth Factor/biosynthesis , Receptor, Nerve Growth Factor/genetics , Recombinant Proteins/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Transfection
13.
Dig Dis Sci ; 54(7): 1449-55, 2009 Jul.
Article in English | MEDLINE | ID: mdl-18958619

ABSTRACT

BACKGROUND AND OBJECTIVE: The canine model of esophageal varices with an agar constrictor has been used for studies of the endoscopic treatment of esophageal variceal bleeding, but it has limitations in both stability and successful rate. This study was designed to enhance the model's efficiency and success rate by using a novel approach with a balloon dilatation constrictor. METHODS: We used 22 adult mongrel dogs to establish the model by progressively compressing and constricting the portal vein through a rechargeable balloon dilatation constrictor in combination with side-to-side portocaval shunt and inferior vena cava (IVC) ligation to increase portal vein pressure (PVP). The rechargeable balloon dilatation constrictor was composed of a hyaline polypropylene (PP) ring, a silica gel tube with a balloon, and an injection pedestal (silica gel) in an implantable vascular access port. The effects were evaluated with pre- and post-shunt PVP measurement, weekly gastroscopy, and portocaval venography. RESULTS: The mean PVP increased significantly from a preoperative (before side-to-side portocaval shunt and IVC ligation) 12.86 +/- 0.18 cmH(2)O to 26.75 +/- 0.39 cmH(2)O after the model had been established (P < 0.05). After the model was established, gastroscopy performed to assess esophageal varix size demonstrated four varicose veins of grade I, six of grade II, eight of grade III and four of grade IV. The portocaval angiography showed that the IVC and portal vein were completely blocked, that the anastomosis stoma was unobstructed and that the blood flow through esophageal varices via splenetic and gastric veins was blocked. CONCLUSION: The novel canine model developed with a rechargeable balloon dilatation constrictor is feasible and reliable for modeling esophageal varices.


Subject(s)
Catheterization/instrumentation , Disease Models, Animal , Esophageal and Gastric Varices , Animals , Constriction, Pathologic , Dogs , Equipment Design , Female , Gastroscopy , Male , Portal Vein/pathology
14.
Biochem Biophys Res Commun ; 372(1): 260-5, 2008 Jul 18.
Article in English | MEDLINE | ID: mdl-18486597

ABSTRACT

During liver injury, bone marrow-derived mesenchymal stem cells (MSCs) can migrate and differentiate into hepatocytes. Hepatic stellate cell (SC) activation is a pivotal event in the development of liver fibrosis. Therefore, we hypothesized that SCs may play an important role in regulating MSC proliferation and differentiation through the paracrine signaling pathway. We demonstrate that MSCs and SCs both express hedgehog (Hh) pathway components, including its ligands, receptors, and target genes. Transwell co-cultures of SCs and MSCs showed that the SCs produced sonic hedgehog (Shh), which enhanced the proliferation and differentiation of MSCs. These findings demonstrate that SCs indirectly modulate the activity of MSCs in vitro via the Hh pathway, and provide a plausible explanation for the mechanisms of transplanted MSCs in the treatment of liver fibrosis.


Subject(s)
Cell Differentiation , Hedgehog Proteins/metabolism , Liver/cytology , Mesenchymal Stem Cells/cytology , Paracrine Communication , Antibodies/pharmacology , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Cell Differentiation/genetics , Cell Line , Cell Proliferation/drug effects , Coculture Techniques , Hedgehog Proteins/antagonists & inhibitors , Hedgehog Proteins/genetics , Humans , Liver/drug effects , Liver/metabolism , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/metabolism , Promoter Regions, Genetic , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transcription Factors/genetics , Zinc Finger Protein GLI1
15.
World J Gastroenterol ; 13(48): 6588-92, 2007 Dec 28.
Article in English | MEDLINE | ID: mdl-18161932

ABSTRACT

AIM: To evaluate the predictive value of D-dimer as a predictive indicator of portal vein thrombosis (PVT) after portal hypertension surgery in hepatitis B virus-related cirrhosis. METHODS: A prospective study was carried out in 52 patients who had undergone surgery for portal hypertension in hepatitis B virus-related cirrhosis. Changes in perioperative dynamic D-dimer were observed. The sensitivity, specificity, positive predictive values and negative predictive values of D-dimer were calculated, and ROC curves were analyzed. RESULTS: The D-dimer levels in the group developing postoperative PVT was significantly higher than those in the group not developing PVT (P = 0.001), and the ROC semiquantitative and qualitative analysis of D-dimer showed a moderate predictive value in PVT (semi-quantitative value Az = 0.794, P = 0.000; qualitative analysis: Az = 0.739, P = 0.001). CONCLUSION: Dynamic monitoring of D-dimer levels in patients with portal hypertension after surgery can help early diagnosis of PVT, as in cases where the D-dimer levels steadily increase and exceed 16 microg/mL, the possibility of PVT is very high.


Subject(s)
Fibrin Fibrinogen Degradation Products/metabolism , Hepatitis B/complications , Hypertension, Portal/etiology , Hypertension, Portal/surgery , Liver Cirrhosis/complications , Portal Vein , Venous Thrombosis/diagnosis , Adult , Female , Hepatitis B virus/pathogenicity , Humans , Liver/blood supply , Liver/surgery , Liver/virology , Liver Cirrhosis/etiology , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity , Venous Thrombosis/blood
16.
World J Gastroenterol ; 13(12): 1851-4; discussion 1854-6, 2007 Mar 28.
Article in English | MEDLINE | ID: mdl-17465480

ABSTRACT

AIM: To study the inhibitory effect of mononuclear bone marrow cell (BMC) transplantation on carbon tetrachloride (CCl(4)) -induced liver fibrosis in rats. METHODS: Rat liver fibrosis models were induced by CCl(4) and alcohol administration. After 8 wk, twenty rats were randomly allocated into treatment group (n = 10) and control group (n = 10). BMC were infused into the rats in treatment group via the portal vein, while heparinized saline was infused in control group. CCl(4) was hypodermically injected into the rats twice a week for 4 wk. At the end of wk 12, all rats were humanely sacrificed. Liver samples were taken and stained with HE or Masson trichrome. The general conditions, liver fibrosis (hydroxyproline and collagen fibre) and liver pathological grades in rats were evaluated. RESULTS: The general conditions of the rats in treatment group improved markedly, but not in control group. Hydroxyproline was 504.6 +/- 128.8 microg/g in treatment group, and 596.0 +/- 341.8 microg/g in control group. The percentage of collagen fibre was 3.75% +/- 0.98% in treatment group and 5.02% +/- 0.44% in control group. There was a significant difference between the two groups (P < 0.05). Liver pathological grade decreased from grade IV to grade III partially in treatment group (P < 0.05) with no obvious improvement in control group (P > 0.05). There was a significant difference between treatment group and control group (P < 0.05). CONCLUSION: Transplantation of BMC can improve liver fibrosis due to chronic liver injury in rats.


Subject(s)
Bone Marrow Cells/physiology , Bone Marrow Transplantation/methods , Liver Cirrhosis, Experimental/prevention & control , Liver Cirrhosis, Experimental/physiopathology , Animals , Bone Marrow Cells/cytology , Carbon Tetrachloride , Collagen/metabolism , Disease Models, Animal , Hydroxyproline/metabolism , Liver/metabolism , Liver/pathology , Liver Cirrhosis, Experimental/chemically induced , Liver Regeneration/physiology , Random Allocation , Rats , Rats, Inbred F344 , Rats, Wistar
17.
World J Gastroenterol ; 13(15): 2223-8, 2007 Apr 21.
Article in English | MEDLINE | ID: mdl-17465506

ABSTRACT

AIM: To evaluate the effects of combined treatment of glutamine (Gln) and recombinant human growth hormone(rhGH) on intestinal barrier function following portal hypertension surgery. METHODS: This study was designed as a prospective, randomized and controlled clinical trial. Forty two patients after portal hypertension surgery were randomly assigned into 2 groups: control group (n = 20) and supplemental group (adding Gln and rhGH, n = 22). Every patient received isocaloric and isonitrogenous standard total parenteral nutrition (TPN) starting 3 d after surgery for 7 d. Blood samples were obtained before surgery and at the 3rd and 10th day postoperatively. Host immunity was evaluated by measuring levels of CD4, CD8, CD4/CD8, IgG, IgM and IgA, and the inflammatory responses were determined by assessing IL-2, TNF-alpha and C-reactive protein (CRP) levels. Intestinal permeability and integrity was evaluated by L/M test and histological examination, respectively. RESULTS: On postoperative d 10, CD4, CD4/CD8, IgG and IL-2 levels in supplemental group were significantly higher than those in control group (33.7 +/- 5.5 vs 31.0 +/- 5.4, P < 0.05, (1.17 +/- 0.32 vs 1.05 +/- 0.15, P < 0.05, 13.94 +/- 1.09 vs 12.33 +/- 1.33, P < 0.05, and 368.12 +/- 59.25 vs 318.12 +/- 45.65, P < 0.05, respectively), whereas the increase in serum TNF-alpha concentration was significantly reduced (41.02 +/- 27.56 vs 160.09 +/- 35.17, P < 0.05). The increase in L/M ratio was significantly lower in the supplemental group than in the control group (0.0166 +/- 0.0017 vs 0.0339 +/- 0.0028, P < 0.05). Moreover, mucosal integrity in the supplemental group was better than in the control group. CONCLUSION: Postoperative administration of TPN supplemented with Gln and rhGH in patients after portal hypertension surgery improves immune function, modulates inflammatory response, prevents the intestinal mucous membrane from atrophy and preserves intestinal integrity.


Subject(s)
Cell Membrane Permeability/physiology , Glutamine/therapeutic use , Human Growth Hormone/therapeutic use , Hypertension, Portal/surgery , Intestinal Absorption/physiology , Recombinant Proteins/therapeutic use , Adult , Atrophy/prevention & control , C-Reactive Protein/metabolism , Cell Membrane Permeability/drug effects , Drug Therapy, Combination , Female , Humans , Immunoglobulins/blood , Interleukin-2/blood , Intestinal Absorption/drug effects , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Intestinal Mucosa/physiology , Lactulose/blood , Male , Mannitol/blood , Middle Aged , Proliferating Cell Nuclear Antigen/blood , Tumor Necrosis Factor-alpha/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...